NCT00342563View on ClinicalTrials.gov

Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Alcoholism
Interventions
DRUG

mecamylamine

mecamylamine 10mg/day

DRUG

Placebo

Placebo

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT00342563 - Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients | Biotech Hunter | Biotech Hunter